HB0034 in Patients With Generalized Pustular Psoriasis (GPP)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of HB0034 in adult patients with generalized pustular psoriasis (GPP ).
Epistemonikos ID: 045d0f51f5bf13b10f8cf2e4f474326d24291b3c
First added on: May 13, 2024